205 related articles for article (PubMed ID: 9808705)
1. Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins.
Apparsundaram S; Schroeter S; Giovanetti E; Blakely RD
J Pharmacol Exp Ther; 1998 Nov; 287(2):744-51. PubMed ID: 9808705
[TBL] [Abstract][Full Text] [Related]
2. Acute regulation of norepinephrine transport: I. protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells.
Apparsundaram S; Galli A; DeFelice LJ; Hartzell HC; Blakely RD
J Pharmacol Exp Ther; 1998 Nov; 287(2):733-43. PubMed ID: 9808704
[TBL] [Abstract][Full Text] [Related]
3. Trafficking-dependent and -independent pathways of neurotransmitter transporter regulation differentially involving p38 mitogen-activated protein kinase revealed in studies of insulin modulation of norepinephrine transport in SK-N-SH cells.
Apparsundaram S; Sung U; Price RD; Blakely RD
J Pharmacol Exp Ther; 2001 Nov; 299(2):666-77. PubMed ID: 11602680
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
5. Amphetamine induces a calcium/calmodulin-dependent protein kinase II-dependent reduction in norepinephrine transporter surface expression linked to changes in syntaxin 1A/transporter complexes.
Dipace C; Sung U; Binda F; Blakely RD; Galli A
Mol Pharmacol; 2007 Jan; 71(1):230-9. PubMed ID: 17032905
[TBL] [Abstract][Full Text] [Related]
6. Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition.
Melikian HE; Ramamoorthy S; Tate CG; Blakely RD
Mol Pharmacol; 1996 Aug; 50(2):266-76. PubMed ID: 8700133
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation by protein kinases of activity and cell surface expression of glutamate transporters in neuron-enriched cultures.
Guillet BA; Velly LJ; Canolle B; Masmejean FM; Nieoullon AL; Pisano P
Neurochem Int; 2005 Mar; 46(4):337-46. PubMed ID: 15707698
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity.
Reith ME; Wang LC; Dutta AK
J Neurosci Methods; 2005 Apr; 143(1):87-94. PubMed ID: 15763140
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of the norepinephrine transporter activity and trafficking via interactions with alpha-synuclein.
Wersinger C; Jeannotte A; Sidhu A
Eur J Neurosci; 2006 Dec; 24(11):3141-52. PubMed ID: 17156375
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C and intracellular calcium are required for amphetamine-mediated dopamine release via the norepinephrine transporter in undifferentiated PC12 cells.
Kantor L; Hewlett GH; Park YH; Richardson-Burns SM; Mellon MJ; Gnegy ME
J Pharmacol Exp Ther; 2001 Jun; 297(3):1016-24. PubMed ID: 11356924
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the human norepinephrine transporter by cocaine and amphetamine.
Zhu MY; Shamburger S; Li J; Ordway GA
J Pharmacol Exp Ther; 2000 Dec; 295(3):951-9. PubMed ID: 11082428
[TBL] [Abstract][Full Text] [Related]
12. Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers.
Mash DC; Ouyang Q; Qin Y; Pablo J
J Neurosci Methods; 2005 Apr; 143(1):79-85. PubMed ID: 15763139
[TBL] [Abstract][Full Text] [Related]
13. Rapid, transient effects of the protein kinase C activator phorbol 12-myristate 13-acetate on activity and trafficking of the rat high-affinity choline transporter.
Black SA; Ribeiro FM; Ferguson SS; Rylett RJ
Neuroscience; 2010 May; 167(3):765-73. PubMed ID: 20167259
[TBL] [Abstract][Full Text] [Related]
14. Functional importance of the C-terminus of the human norepinephrine transporter.
Distelmaier F; Wiedemann P; Brüss M; Bönisch H
J Neurochem; 2004 Nov; 91(3):537-46. PubMed ID: 15485485
[TBL] [Abstract][Full Text] [Related]
15. The N-terminus of the norepinephrine transporter regulates the magnitude and selectivity of the transporter-associated leak current.
Binda F; Lute BJ; Dipace C; Blakely RD; Galli A
Neuropharmacology; 2006 Mar; 50(3):354-61. PubMed ID: 16289633
[TBL] [Abstract][Full Text] [Related]
16. KCl stimulation increases norepinephrine transporter function in PC12 cells.
Mandela P; Ordway GA
J Neurochem; 2006 Sep; 98(5):1521-30. PubMed ID: 16879714
[TBL] [Abstract][Full Text] [Related]
17. Human norepinephrine transporter. Biosynthetic studies using a site-directed polyclonal antibody.
Melikian HE; McDonald JK; Gu H; Rudnick G; Moore KR; Blakely RD
J Biol Chem; 1994 Apr; 269(16):12290-7. PubMed ID: 8163533
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of norepinephrine transporter expression on membrane surface induced by chronic administration of desipramine and the antagonism by co-administration of local anesthetics in mice.
Song L; Kitayama T; Morita K; Morioka N; Dohi T
Neurochem Int; 2008; 52(4-5):826-33. PubMed ID: 17981365
[TBL] [Abstract][Full Text] [Related]
19. Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter.
Schroeter S; Apparsundaram S; Wiley RG; Miner LH; Sesack SR; Blakely RD
J Comp Neurol; 2000 May; 420(2):211-32. PubMed ID: 10753308
[TBL] [Abstract][Full Text] [Related]
20. Catechol-O-methyltransferase activity in CHO cells expressing norepinephrine transporter.
Percy E; Kaye DM; Lambert GW; Gruskin S; Esler MD; Du XJ
Br J Pharmacol; 1999 Oct; 128(3):774-80. PubMed ID: 10516661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
